| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.38B | 92.35B | 91.70B | 88.72B | 82.36B | 75.65B |
| Gross Profit | 19.83B | 20.86B | 20.54B | 18.02B | 14.63B | 15.80B |
| EBITDA | 6.36B | 6.91B | 7.25B | 5.65B | 2.88B | 4.41B |
| Net Income | 2.84B | 2.93B | 3.50B | 2.73B | 485.00M | 1.21B |
Balance Sheet | ||||||
| Total Assets | 63.08B | 63.92B | 64.08B | 67.37B | 63.01B | 61.76B |
| Cash, Cash Equivalents and Short-Term Investments | 14.69B | 13.49B | 15.73B | 15.73B | 12.29B | 12.44B |
| Total Debt | 3.69B | 3.29B | 5.51B | 6.45B | 5.50B | 10.47B |
| Total Liabilities | 23.00B | 22.35B | 24.11B | 28.39B | 26.21B | 25.22B |
| Stockholders Equity | 40.08B | 41.56B | 39.96B | 38.98B | 36.79B | 36.54B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 280.00M | 4.07B | 5.68B | 2.94B | 3.53B |
| Operating Cash Flow | 0.00 | 2.94B | 4.59B | 5.96B | 3.53B | 3.76B |
| Investing Cash Flow | 0.00 | -2.71B | -1.06B | -239.00M | -856.00M | -419.00M |
| Financing Cash Flow | 0.00 | -2.48B | -3.53B | -2.28B | -2.82B | -3.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥4.74T | 23.62 | 9.46% | 1.32% | 3.47% | 99.65% | |
71 Outperform | ¥1.39T | 21.75 | 11.19% | 1.46% | 5.16% | 1.57% | |
71 Outperform | ¥575.76B | 28.74 | 9.28% | 1.30% | 5.86% | -17.47% | |
66 Neutral | ¥130.99B | 24.96 | ― | 1.08% | 4.45% | 11.13% | |
65 Neutral | ¥31.80B | 11.09 | ― | 2.23% | 0.71% | -9.71% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | ¥166.25B | 7.50 | 12.56% | 3.44% | 4.40% | 91.05% |